Age and basal follicle stimulating hormone as predictors of in vitro fertilisation outcome

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 105, Issue 1, 1998, Pages 107-112

  Sharif, Khaldoun ^a   Elgendy, Manal ^a   Lashen, Hany ^a   Afnan, Masoud ^a  

^a BIRMINGHAM WOMEN S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHORIONIC GONADOTROPIN; FOLLITROPIN; GONADORELIN; HUMAN MENOPAUSAL GONADOTROPIN; NAFARELIN; UROFOLLITROPIN;

ADULT; AGE; ARTICLE; FEMALE; FERTILIZATION IN VITRO; HUMAN; MAJOR CLINICAL STUDY; OOCYTE; PREGNANCY RATE; PRIORITY JOURNAL;

ADULT; AGE FACTORS; FEMALE; FERTILIZATION IN VITRO; FOLLICLE STIMULATING HORMONE; GONADOTROPINS; HUMANS; MIDDLE AGED; OVARY; PREGNANCY;

EID: 0031973891     PISSN: 14700328     EISSN: 14710528     Source Type: Journal    
DOI: 10.1111/j.1471-0528.1998.tb09360.x     Document Type: Article

References (12)

1. Federation CECOS, Schwartz D, Mayaux BA. Female fecundity as a function of age: Results of artificial insemination in 2193 nulliparous women with azoospermic husbands. N Engl J Med 1982; 306: 404–406.
2. Templeton A, Moms JK, Parslow W. Factors that affect outcome of in-vitro fertilisation treatment. Lancet 1996; 348: 1402–1406.
3. Sherman BM, Korenman SG. Hormonal characteristics of the human menstrual cycle throughout reproductive life. J Clin Invest 1975; 55: 699–706.
4. Lenton EA, Sexton L, Lee S, Cook ID. Progressive changes in LH and FSH and LH: Fsh ratio in women throughout reproductive life. Maturitas 1988; 10: 35–43.
5. Scott RT, Toner JP, Muasher SJ, Oehninger S, Robinson S, Rosenwaks Z. Follicle-stimulating hormone levels on cycle day 3 are predictive of in vitro fertilization outcome. Ferfil Steril 1989; 51: 651–654.
6. Toner JP, Philput CB, Jones GS, Muasher SJ. Basal follicle stimulating hormone level is a better predictor of in vitro fertilisation performance than age. Feriil Steril 1991; 55: 784–791.
7. Cahill DJ, Prosser CJ, Wardle PG, Ford WCL, Hull MGR. Relative influence of serum follicle stimulating hormone, age, and other fac- tors on ovarian response to gonadotrophin stimulation. Br J Obstet Gynaecol 1994; 101: 999–1002.
8. Sharif K, Afnan M, Lenton W. Mock embryo transfer with a full-blad- der immediately before the real transfer for in-vitro fertilisation treatment: The Birmingham experience of 113 cases. Hum Reprod 1995; 10: 1715–1718.
9. Sharif K, Afnan M, Lenton W, Bilalis D, Hunjan M, Khalaf Y. Transmyometrial embryo transfer following difficult immediate mock transcervical transfer. Fertil Steril 1996: 56: 1071–1074.
10. Land JA, Yarmolinskaya MI, Dumoulin JCM, Evers JLH. Highdose human menopausal gonadotropin stimulation in poor responders does not improve in vitro fertilization outcome. Fertil Steril 1996; 65: 961–965.
11. Hansen LM, Batzer FR, Gutmann JN, Corson SL, Kelly MP, Gocial B. Evaluating ovarian reserve: Follicle stimulating hormone and oestradiol variability during cycle days 2–5. Hum Reprod 1996; 11: 486–489.
12. Scott RT, Hofmann GE, Oehninger S, Muasher SJ. Intercycle variability of day 3 follicle-stimulating hormone levels and its effect on stimulatation quality in in vitro fertilization. Fertil Steril 1990; 54: 297–302.